Proactive Investors - Run By Investors For Investors

Novaliq making headway with its water-free eye drops

Novaliq CEO Christian Roesky sat down with Proactive Investors at the 11th Annual Biotech Showcase in San Francisco.

The Heidelberg, Germany based pharmaceutical company is focusing on the development and commercialization of ocular therapeutics based on EyeSol, a water-free technology for ophthalmology products.

View full NOVAL profile View Profile

Novaliq Timeline

Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use